Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Rosty

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 30, 2004
Wide metastatic spreading in infiltrating lobular carcinoma of the breastS Ferlicot, A Vincent-Salomon, J Médioni, et al.
The American Journal of Pathology|December 6, 2001
STK11/LKB1 Peutz-Jeghers gene inactivation in intraductal papillary-mucinous neoplasms of the pancreasN Sato, C Rosty, M Jansen, et al.
Anticancer Research|October 30, 2004
Analysis of correlation between mitotic index, MIB1 score and S-phase fraction as proliferation markers in invasive breast carcinoma. Methodological aspects and prognostic value in a series of 257 casesM Caly, P Genin, Al Ghuzlan A, et al.
Histopathology|July 29, 2004
Increased cell size and Akt activation in HER-2/neu-overexpressing invasive ductal carcinoma of the breastX Sastre-Garau, P Genin, A Rousseau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
The SMAD4 protein and prognosis of pancreatic ductal adenocarcinomaM Tascilar, H G Skinner, C Rosty, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE)P Argani, C Iacobuzio-Donahue, B Ryu, et al.
Cancer Research|June 5, 2001
Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinomaP Argani, C Rosty, R E Reiter, et al.
Clinical Genetics|September 29, 2012
Absence of PMS2 mutations in colon-CFR participants whose colorectal cancers demonstrate unexplained loss of MLH1 expressionM Clendenning, F A Macrae, M D Walsh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2017
Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker studyR Dienstmann, M J Mason, F A Sinicrope, et al.
British Journal of Cancer|June 12, 2014
Characterisation of familial colorectal cancer Type X, Lynch syndrome, and non-familial colorectal cancerS Shiovitz, W K Copeland, M N Passarelli, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
European Journal of Cancer (Oxford, England : 1990)|January 30, 2004
Wide metastatic spreading in infiltrating lobular carcinoma of the breastS Ferlicot, A Vincent-Salomon, J Médioni, et al.
The American Journal of Pathology|December 6, 2001
STK11/LKB1 Peutz-Jeghers gene inactivation in intraductal papillary-mucinous neoplasms of the pancreasN Sato, C Rosty, M Jansen, et al.
Anticancer Research|October 30, 2004
Analysis of correlation between mitotic index, MIB1 score and S-phase fraction as proliferation markers in invasive breast carcinoma. Methodological aspects and prognostic value in a series of 257 casesM Caly, P Genin, Al Ghuzlan A, et al.
Histopathology|July 29, 2004
Increased cell size and Akt activation in HER-2/neu-overexpressing invasive ductal carcinoma of the breastX Sastre-Garau, P Genin, A Rousseau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
The SMAD4 protein and prognosis of pancreatic ductal adenocarcinomaM Tascilar, H G Skinner, C Rosty, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE)P Argani, C Iacobuzio-Donahue, B Ryu, et al.
Cancer Research|June 5, 2001
Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinomaP Argani, C Rosty, R E Reiter, et al.
Clinical Genetics|September 29, 2012
Absence of PMS2 mutations in colon-CFR participants whose colorectal cancers demonstrate unexplained loss of MLH1 expressionM Clendenning, F A Macrae, M D Walsh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2017
Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker studyR Dienstmann, M J Mason, F A Sinicrope, et al.
British Journal of Cancer|June 12, 2014
Characterisation of familial colorectal cancer Type X, Lynch syndrome, and non-familial colorectal cancerS Shiovitz, W K Copeland, M N Passarelli, et al.
Pageof 3